Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
authorized generics
Pharma
Lotus grows US generics business with acquisition of Alvogen
Serial entrepreneur Robert Wessman has brought together two of his fastest-growing companies as Lotus has acquired a 100% equity stake in Alvogen.
Kevin Dunleavy
Sep 26, 2025 9:20am
Takeda, Endo hit with antitrust suit over pay-for-delay deal
Jun 30, 2021 11:42am
Gilead’s hep C generics now own more than 20% of market
Sep 16, 2019 11:34am
Novo to roll out authorized insulin generics at half price
Sep 6, 2019 12:35pm
Drugmakers master rolling out generics to stifle competition
Aug 5, 2019 8:15am
Will Novo and Sanofi follow Lilly's generic Humalog move?
Mar 7, 2019 12:16pm
